All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @kristinecarrollfitness on Instagram · 5s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @kristinecarrollfitness's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Over the mountains and sea, your river runs with love

@kristinecarrollfitness shares her mental health struggles

Kristine | GLP-1 + Midlife

Instagram creator

175.8K viewsView on Instagram

Quick answer

Perimenopause is a documented high-risk period for mood destabilization in women with bipolar disorder, driven by erratic estrogen fluctuations that disrupt serotonergic and dopaminergic signaling. The caption describes classic perimenopausal psychiatric presentation in a vulnerable population, but the TRT categorization raises clinical questions, as testosterone therapy in women with bipolar disorder requires careful psychiatric oversight given its effects on mood and sleep. Viewers should not interpret this creator's personal hormone journey as evidence that TRT is an appropriate or safe intervention for perimenopausal mood symptoms in bipolar disorder.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @kristinecarrollfitness shares her mental health struggles, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@kristinecarrollfitness shares her mental health struggles is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@kristinecarrollfitness shares her mental health struggles" from Kristine | GLP-1 + Midlife. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Perimenopause is a documented high-risk period for mood destabilization in women with bipolar disorder, driven by erratic estrogen fluctuations that disrupt serotonergic and dopaminergic signaling.

The reason this review is not generic is the source wording and the canonical claim label "trt how hard it was going to be yesterday i literally had a c." In this clip, the useful excerpt is: "Over the mountains and sea, your river runs with love" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Estrogen's role in modulating serotonin and dopamine systems means that perimenopausal hormone fluctuations can destabilize mood in neurologically sensitive individuals.
People who land here are usually comparing the Testosterone claim with Perimenopause, Menopausetransition, and Hormonalchanges.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Perimenopause is a documented high-risk period for mood destabilization in women with bipolar disorder, driven by erratic estrogen fluctuations that disrupt serotonergic and dopaminergic signaling.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Perimenopause is a documented high-risk period for mood destabilization in women with bipolar disorder, driven by erratic estrogen fluctuations that disrupt serotonergic and dopaminergic signaling. The caption describes classic perimenopausal psychiatric presentation in a vulnerable population, but the TRT categorization raises clinical questions, as testosterone therapy in women with bipolar disorder requires careful psychiatric oversight given its effects on mood and sleep. Viewers should not interpret this creator's personal hormone journey as evidence that TRT is an appropriate or safe intervention for perimenopausal mood symptoms in bipolar disorder.
  • Women with bipolar disorder are at significantly elevated risk of depressive episodes during perimenopause, per Marsh et al. (2018, Bipolar Disorders).
  • Estrogen's role in modulating serotonin and dopamine systems means that perimenopausal hormone fluctuations can destabilize mood in neurologically sensitive individuals.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Women with bipolar disorder are at significantly elevated risk of depressive episodes during perimenopause, per Marsh et al. (2018, Bipolar Disorders).
  • Estrogen's role in modulating serotonin and dopamine systems means that perimenopausal hormone fluctuations can destabilize mood in neurologically sensitive individuals.
  • Estradiol-based hormone therapy has RCT-level evidence for perimenopausal depression; testosterone therapy for mood in women does not have comparable support.
  • Mood stabilizer and antidepressant metabolism can be altered by hormonal changes, meaning existing psychiatric medication regimens may need review during perimenopause.
  • The SWAN longitudinal study identified perimenopause as the hormonal life stage most associated with new depressive episodes in previously non-depressed women.
  • Anyone with a pre-existing psychiatric diagnosis entering perimenopause should coordinate care between a psychiatrist and a menopause-informed clinician, not rely on social media for treatment decisions.
  • Testosterone therapy in women with bipolar disorder is not a casual intervention and its mood effects, including on sleep and irritability, require monitoring by a qualified provider.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @kristinecarrollfitness actually say?

Honestly, not much, at least not in the transcript. The audio captured in this video is a song lyric, "Over the mountains and sea, your river runs with love," which tells us nothing medically useful. What we actually have to work with is the caption, where Kristine describes sobbing, a breakdown, and a depression she says is unlike anything she's experienced, all while managing a pre-existing bipolar disorder diagnosis during what she tags as perimenopause.

That caption context is real, emotionally raw, and worth taking seriously. But the video itself, at least as transcribed, contains zero health claims. So this fact-check is built on what she wrote, not what she said on camera.

Does the science back this up?

Yes, and significantly so. The connection between perimenopause and worsening mood disorders is one of the more robust findings in women's hormonal health research. This is not fringe stuff.

Women with pre-existing mood disorders like bipolar disorder are at substantially elevated risk of psychiatric destabilization during perimenopause. A 2018 study by Marsh and colleagues in the journal Bipolar Disorders found that perimenopausal women with bipolar disorder reported significantly more depressive episodes than premenopausal peers, and that mood instability often preceded or coincided with menstrual irregularity and vasomotor symptoms like hot flashes and night sweats.

The mechanism isn't mysterious. Estrogen modulates serotonin, dopamine, and norepinephrine systems. As estrogen levels fluctuate erratically in perimenopause, those neurotransmitter systems get destabilized. For someone whose brain chemistry is already sensitized by bipolar disorder, that added volatility can hit harder and faster than it would for someone without a mood disorder history.

  • Freeman et al. (2006, Biological Psychiatry) identified perimenopause as a high-risk window for new and recurrent depression.
  • Burt et al. (2002, American Journal of Psychiatry) found bipolar women were particularly vulnerable during hormonal transitions.

What did they get wrong (or right)?

Kristine didn't make specific medical claims in the transcript, so there's nothing factually incorrect to flag there. What she got right, at least in her caption, is describing something clinically real. The experience of feeling a depressive low she hasn't felt before, in the context of perimenopause and a bipolar diagnosis, is consistent with what the literature describes.

What she doesn't address, and what viewers might incorrectly assume from the hormone-heavy hashtags, is whether testosterone replacement therapy is the appropriate response to what she's experiencing. The video is categorized under TRT, and that framing deserves scrutiny.

TRT in women is sometimes used off-label for mood, energy, and libido during the menopause transition, but the evidence base is far thinner than it is for estrogen-based therapies. More importantly, adding exogenous testosterone to someone managing bipolar disorder isn't a casual decision. Testosterone can influence mood, aggression, and sleep architecture, all variables that matter significantly in bipolar management. No content creator should be implying TRT is a solution to a bipolar episode, and to her credit, Kristine doesn't explicitly say that here. But the categorization and hashtag framing nudges viewers in that direction.

What should you actually know?

If you have bipolar disorder and you're entering perimenopause, you are in a genuinely higher-risk period. That's not alarmist, it's documented. Your existing psychiatric treatment plan may need adjustment, and that conversation belongs with a psychiatrist who also understands hormonal health, ideally in coordination with a gynecologist or menopause specialist.

A few things worth knowing:

  • Hormone therapy, specifically estradiol, has actual evidence behind it for perimenopausal depression. The SWAN study and multiple RCTs support this. TRT for mood in women is a much weaker evidence story.
  • Mood stabilizers and antidepressants may need dose or formulation review during perimenopause because hormone fluctuations can alter drug metabolism.
  • Tracking your cycle and mood together, using something as simple as a diary or app, can help your care team see patterns that are otherwise invisible.
  • Crying, emotional overwhelm, and feeling like your mental health foundation has shifted are reported by a significant proportion of perimenopausal women. It doesn't mean your bipolar disorder is out of control, but it does mean you need support, not just symptom management.

What Kristine is experiencing sounds real and hard. The science agrees with her gut feeling that perimenopause is making things worse. What it can't do is tell you whether what she's doing about it is the right call for anyone else.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Kristine | GLP-1 + Midlife · Instagram creator

175.8K views on this video

How hard it was going to be. Yesterday I literally had a complete breakdown. I sobbed for what seemed like forever. I had no idea it would be this difficult. I am already bipolar and I work ver

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about women with bipolar disorder?

Women with bipolar disorder are at significantly elevated risk of depressive episodes during perimenopause, per Marsh et al. (2018, Bipolar Disorders).

What does the video say about estrogen's role in modulating serotonin?

Estrogen's role in modulating serotonin and dopamine systems means that perimenopausal hormone fluctuations can destabilize mood in neurologically sensitive individuals.

What does the video say about estradiol-based hormone therapy has rct-level evidence for perimenopausal depression; testosterone?

Estradiol-based hormone therapy has RCT-level evidence for perimenopausal depression; testosterone therapy for mood in women does not have comparable support.

What does the video say about mood stabilizer?

Mood stabilizer and antidepressant metabolism can be altered by hormonal changes, meaning existing psychiatric medication regimens may need review during perimenopause.

What does the video say about the swan longitudinal study identified perimenopause as the hormonal life?

The SWAN longitudinal study identified perimenopause as the hormonal life stage most associated with new depressive episodes in previously non-depressed women.

What does the video say about anyone with a pre-existing psychiatric diagnosis entering perimenopause should coordinate?

Anyone with a pre-existing psychiatric diagnosis entering perimenopause should coordinate care between a psychiatrist and a menopause-informed clinician, not rely on social media for treatment decisions.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Kristine | GLP-1 + Midlife, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.